Advertisements

Aurobindo Q4 PAT seen up 25.3% YoY to Rs. 648.2 cr: Edelweiss

Aurobindo Q4 PAT seen up 25.3% YoY to Rs. 648.2 cr: Edelweiss.....»»

Category: topSource: moneycontrolApr 16th, 2018

Aurobindo Pharma arm enters pact to form JV in China with Luoxin

Aurobindo Pharma arm enters pact to form JV in China with Luoxin.....»»

Category: topSource: moneycontrolDec 11th, 2018

Edelweiss group NBFC arm to raise up to Rs 1,000 cr via debt instrument

Edelweiss group NBFC arm to raise up to Rs 1,000 cr via debt instrument.....»»

Category: topSource: moneycontrolDec 6th, 2018

Buy Aurobindo Pharma, target Rs 950: Aditya Agarwala

Buy Aurobindo Pharma, target Rs 950: Aditya Agarwala.....»»

Category: topSource: moneycontrolDec 5th, 2018

Edelweiss Financial up 5% on report of global PE firms eyeing stake in GWAM

Edelweiss Financial up 5% on report of global PE firms eyeing stake in GWAM.....»»

Category: topSource: moneycontrolDec 4th, 2018

From Jefferies to Edelweiss, here"s how brokerages interpret HUL-GSK deal - Business Standard

From Jefferies to Edelweiss, here"s how brokerages interpret HUL-GSK deal - Business Standard.....»»

Category: topSource: googlenewsDec 4th, 2018

Bharti Enterprises sells Future Retail#39;s shares worth around Rs 300 crore

Bharti Enterprises sells Future Retail#39;s shares worth around Rs 300 crore.....»»

Category: topSource: moneycontrolNov 29th, 2018

HCL Tech, Bajaj Finance to replace Wipro, Adani Ports on Sensex

HCL Tech, Bajaj Finance to replace Wipro, Adani Ports on Sensex.....»»

Category: economySource: sifyNov 23rd, 2018

Axis Capital head, former Edelweiss CEO submit bids for IDFC#39;s brokerage arm

Axis Capital head, former Edelweiss CEO submit bids for IDFC#39;s brokerage arm.....»»

Category: topSource: moneycontrolNov 22nd, 2018

Aurobindo inks pact to acquire Australian pharma firm#39;s product

Aurobindo inks pact to acquire Australian pharma firm#39;s product.....»»

Category: topSource: moneycontrolNov 13th, 2018

Stocks in the news: Jet Airways, Tata Steel, MMTC, Coal India, Sun Pharma, HCL Tech, Lupin

Stocks in the news: Jet Airways, Tata Steel, MMTC, Coal India, Sun Pharma, HCL Tech, Lupin.....»»

Category: topSource: moneycontrolNov 12th, 2018

Aurobindo Pharma beats Q2 profit estimates, buys inhalation assets from Australian firm

Aurobindo Pharma beats Q2 profit estimates, buys inhalation assets from Australian firm.....»»

Category: topSource: moneycontrolNov 12th, 2018

Aurobindo Pharma second-quarter profit falls nearly 22 percent

Aurobindo Pharma second-quarter profit falls nearly 22 percent.....»»

Category: global-financeSource: reutersNov 12th, 2018

Q2 preview: Muted US business growth likely to hit Aurobindo Pharma#39;s performance

Q2 preview: Muted US business growth likely to hit Aurobindo Pharma#39;s performance.....»»

Category: topSource: moneycontrolNov 11th, 2018

Nifty target for Diwali 2019 at 11,500, like Biocon, Sun Pharma for long term: Edelweiss

Nifty target for Diwali 2019 at 11,500, like Biocon, Sun Pharma for long term: Edelweiss.....»»

Category: topSource: moneycontrolNov 8th, 2018

Diwali picks: Aurobindo Pharma and Axis Bank among top buys for next 1 year

Diwali picks: Aurobindo Pharma and Axis Bank among top buys for next 1 year.....»»

Category: topSource: moneycontrolNov 6th, 2018

Buy Aurobindo Pharma, target Rs 925: Aditya Agarwala

Buy Aurobindo Pharma, target Rs 925: Aditya Agarwala.....»»

Category: topSource: moneycontrolNov 1st, 2018

Buy Aurobindo Pharma, target Rs 850: Abhishek Mondal

Buy Aurobindo Pharma, target Rs 850: Abhishek Mondal.....»»

Category: topSource: moneycontrolOct 31st, 2018

Asset allocation: 5 ways to reconstruct your portfolio to create wealth

Asset allocation: 5 ways to reconstruct your portfolio to create wealth.....»»

Category: topSource: moneycontrolOct 27th, 2018

Pledged promoter holdings fall to Rs 2.12 lakh crore in Q2: Edelweiss Securities

Pledged promoter holdings fall to Rs 2.12 lakh crore in Q2: Edelweiss Securities.....»»

Category: topSource: moneycontrolOct 26th, 2018

Buy Aurobindo Pharma, target Rs 759: Ashish Chaturmohta

Buy Aurobindo Pharma, target Rs 759: Ashish Chaturmohta.....»»

Category: topSource: moneycontrolOct 23rd, 2018